Valuation: AstraZeneca PLC

Market Cap 26TCr 23TCr 21TCr 20TCr 37TCr 25,24900Cr 37TCr 2,54300Cr 99TCr 12,41300Cr 98TCr 96TCr 42,91900Cr P/E 2026 *
21.1x
P/E 2027 * 18.5x
Enterprise Value 28TCr 25TCr 23TCr 21TCr 40TCr 27,09700Cr 40TCr 2,72900Cr 1,06600Cr 13,32200Cr 1,05600Cr 1,03400Cr 46,06100Cr EV / Sales 2026 *
4.45x
EV / Sales 2027 * 4.1x
Free-Float
96.63%
Yield 2026 *
1.98%
Yield 2027 * 2.08%

Last Transcript: AstraZeneca PLC

1 day+0.59%
Current month+82.45%
6 months+79.62%
Current year+84.12%
Current year 89.04
Extreme 89.04
170.26
1 year 71.49
Extreme 71.49
170.26
3 years 60.47
Extreme 60.47
170.26
5 years 52.65
Extreme 52.65
170.26
10 years 25.55
Extreme 25.55
170.26
Manager TitleAgeSince
Chief Executive Officer 66 01/10/2012
Director of Finance/CFO 52 01/08/2021
Compliance Officer - 01/01/2023
Director TitleAgeSince
Director/Board Member 70 06/04/1999
Director/Board Member 66 01/10/2012
Director/Board Member 65 27/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
+0.59%+0.21% - - 26TCr
+0.86%+1.43%+48.50%+160.39% 1,05700Cr
+1.59%+4.09%+55.34%+53.96% 62TCr
+0.95%+1.91%+35.91%+81.14% 45TCr
+1.60%+6.25%+33.95%+29.84% 34TCr
-0.60%+1.52%+35.68%+39.76% 30TCr
+0.09%-2.82%-28.29%-41.71% 22TCr
+1.22%+2.66%+21.87%+59.73% 20TCr
-1.18%-3.70%+14.23%+66.51% 16TCr
-0.16%-2.04%-3.20%-34.58% 14TCr
Average +0.38%+0.97%+23.78%+46.12% 38.83TCr
Weighted average by Cap. +0.56%+1.85%+35.61%+77.54%

Financials

2026 *2027 *
Net sales 6.32TCr 5.55TCr 5.16TCr 4.74TCr 8.9TCr 6,08700Cr 9.04TCr 61TCr 24TCr 2,99200Cr 24TCr 23TCr 10,34600Cr 6.68TCr 5.87TCr 5.45TCr 5.01TCr 9.4TCr 6,43100Cr 9.55TCr 65TCr 25TCr 3,16200Cr 25TCr 25TCr 10,93100Cr
Net income 1.24TCr 1.09TCr 1.02TCr 931.72Cr 1.75TCr 1,19700Cr 1.78TCr 12TCr 4.71TCr 59TCr 4.67TCr 4.57TCr 2,03500Cr 1.39TCr 1.22TCr 1.14TCr 1.04TCr 1.96TCr 1,34100Cr 1.99TCr 14TCr 5.28TCr 66TCr 5.23TCr 5.12TCr 2,28000Cr
Net Debt 1.92TCr 1.69TCr 1.57TCr 1.44TCr 2.7TCr 1,84900Cr 2.74TCr 19TCr 7.27TCr 91TCr 7.21TCr 7.05TCr 3,14200Cr 1.19TCr 1.05TCr 972.21Cr 892.13Cr 1.68TCr 1,14600Cr 1.7TCr 12TCr 4.51TCr 56TCr 4.47TCr 4.37TCr 1,94800Cr
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
24/26/24 $169.26 +0.59% 20,09,993
23/26/23 $168.27 -0.86% 23,94,069
22/26/22 $169.73 +0.23% 16,83,823
21/26/21 $169.34 +2.93% 19,86,357
20/26/20 $164.52 -2.59% 25,52,981
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
169.04USD
Average target price
212.16USD
Spread / Average Target
+25.51%

Quarterly revenue - Rate of surprise